Aurion Biotech named Edward J. Holland, MD, chief medical advisor of the company where he will work with the executive team to advance cell therapy for the treatment of corneal endothelial disease.
“Dr. Holland has been an innovator in corneal surgery for his entire career, which is why he recognized very early on that corneal endothelial cell therapy is a game-changer. He has been one of Aurion Biotech’s strongest supporters and we are honored that he’ll deepen his engagement with us,” Greg Kunst, chief executive officer of Aurion Biotech, said (Read more...)